Hoag offers CyberKnife® as a technologically advanced treatment option in the fight against cancer.

Hoag collaborates with Newport Diagnostic Center (NDC) to offer this as another minimally-invasive treatment option part of Hoag’s comprehensive, personalized and integrated approach to cancer treatment. The CyberKnife® offers a renewed sense of hope to patients who may not be surgical candidates, while often providing an excellent adjunct therapy for those patients undergoing cancer surgery.

The CyberKnife is an FDA-cleared, non-invasive, robotic radiosurgery system that treats both cancerous and non-cancerous tumors with sub-millimeter accuracy. In the care of Hoag-affiliated Radiation Oncologist Amanda Schwer, M.D., patients are treated in single or fractioned doses (typically in 1-5 sessions) by delivering multiple beams of precisely directed radiation that converge upon the tumor, minimizing damage to surrounding healthy tissue. With the unique ability to provide sub-millimeter precision and thereby spare healthy tissue, the CyberKnife is often capable of safely delivering curative doses in cases which were previously considered untreatable. The CyberKnife is capable of treating tumors and lesions located in the brain, spine, prostate, lung, liver and pancreas; virtually anywhere in the body.

CyberKnife treatment is located in Newport Beach at 1605 Avocado Avenue, at Newport Diagnostic Center.

For more information, or to determine if your patient is qualified for CyberKnife, please call 949-467-3061.